In vitro and in vivo assessments for developing an oral BCG vaccine formulation

Journal of Food and Drug Analysis

Volumn 15, Issue 3, 2007, Pages 213-219

  Chen, Jiin Long ^a   Yu, Chia Chia ^a   Chiang, Jen Ron ^b   Lee, Te Cheng ^a   Yeh, Ming Kung ^c   Chiang, Chiao Hsi ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

BCA method; BCG potency; Intestinal delivery; Oral BCG vaccine

Indexed keywords

BCG VACCINE; IMMUNOGLOBULIN G; TUBERCULIN;

ACCURACY; ANALYTIC METHOD; ANALYTICAL ERROR; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG ANALYSIS; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG POTENCY; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; GASTROINTESTINAL TRACT; GUINEA PIG; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PH; PHYSICAL CHEMISTRY; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; SIMULATION; TEMPERATURE SENSITIVITY; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

CAVIA;

EID: 36448995800     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Dye, C., Scheele, S., Dolin, P., Pathania, V. and Raviglione, M. C. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. TAMA 282: 677-686.
2. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 1339-1345.
3. Lagranderie, M. R., Balazuc, A. M., Deriaud, E., Leclerc, C. D. and Gheorghiu, M. 1996. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect. Immun. 64: 1-9.
4. Brewer, T. F. 2000. Preventing tuberculosis with Bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin. Infect. Dis. 31 (Suppl. 3): S64-S67.
5. Golditz, G. A., Berkey, C. S., Mosteller, F., Brewer, T. F., Wilson, M. E., Burdick, E. and Fineberg, H. V. 1995. The efficacy of Bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analysis of the published literature. Pediatrics 96: 29-35.
6. Golditz, G. A., Brewer, T. F., Berkey, C. S., Wilson, M. E., Burdick, E., Fineberg, H. V. and Mosteller, F. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271: 698-702.
7. Lagranderie, M., Chavarot, P., Balazuc, A. M. and Marchal, G. 2000. Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice. Vaccine 18: 1186-1195.
8. Donikian, R., Gheorghiu, M. and Jablokova, T. B. 1987. Requirments for dried BCG vaccine. WHO Tech. Rep. Ser. 745: 126-159.
9. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Hujimoto, E. K., Goeke, N. M., Olson, B. J. and Klenk, D. C. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
10. Escobar-Gutierrez, A., Amezcua-Chavarria, M. E., Pasten-Sanchez, S., Ramirez-Casanova, E., Cazares, J. V., Granados, G., Loo-Mendez, E. and Cicero, R. 1996. Enzyme-linked immunosorbent assay (ELISA) with mycobacterial crude antigens for the sero-epidemiological diagnosis of active tuberculosis. Int. J. Lepr Other Mycobact. Dis. 64: 417-427.
11. Bartow, R. A. and McMurray, D. N. 1989. Vaccination with Mycobacterium bovis BCG affects the distribution of Fc receptor-bearing T lymphocytes in experimental pulmonary tuberculosis. Infect. Immun. 57: 1374-1379.
12. Aldwell, F. E., Tucker, I. G., deLisle, G. W. and Buddle, B. M. 2003. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice. Infect. Immun. 71: 101-108.
13. Gheorghiu, M., Lagranderie, M. and Balazuc, A. M. 1996. Stabilisation of BCG vaccines. Dev. Biol. Stand. 87: 251-261.
14. Kairo, S. K., Bedwell, J., Tyler, P. C., Carter, A. and Corbel, M. J. 1999. Development of a tetrazolium salt assay for rapid determination of viability of BCG vaccines. Vaccine 17: 2423-2428.
15. Kuan, C. P. and Lin, C. P. 2003. Detection of BCG vaccine by capillary electrophoresis. J. Food Drug Anal. 11: 92-95.
16. Askgard, D. S., Gottschau, A. Knudsen, K. and Bennedsen, J. 1995. Firefly luciferase assay of adenosine triphosphate as a tool of quantitation of the viability of BCG vaccines. Biologicals 23: 55-60.
17. Umadevi, K. R. and Ramalingam, B. 2002. Qualitative and quantitative analysis of antibody response in childhood tuberculosis against antigens of Mycobacterium tuberculosis. Indian J. Med. Microbio. 20: 145-149.
18. McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M. and Kiyono, H. 1992. The mucosal immune system from fundamental concepts to vaccine development. Vaccine 10: 75-88.
19. Buddle, B. M., deLisle, G. W., Pfeffer, A. and Aldwell, F. E. 1995. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13: 1123-1130.
20. Broccolo, F., Scarpellini, P., Locatelli, G., Zingale, A., Brambilla, A. M., Cichero, P., Sechi, L. A., Lazzarin, A., Lusso, P. and Malnati, M. S. 2003. Rapid diagnosis of mycobacterial infections and quantitation of Mycobacterium tuberculosis load by two real-time calibrated PCR assays. J. Clin. Microbiol. 41: 4565-4572.
21. Hellyer, T. J., DesJardin, L. E., Teixeira, L., Perkins, M. D., Cave, M. D. and Eisenach, K. D. 1999. Detection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplification of mRNA. J. Clin. Microbiol. 37: 518-523.